46 min
Seminar, Hosted by U.S. Food and Drug Administration
FDA Grand Rounds presented by the Office of Women’s Health: FDA Menopausal Hormone Therapy (MHT) Labeling: Historical Context and Recent Changes
Nicholas Hazen, M.D. and Aisha Johnson, M.D., MPH, MBA
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Recording
Abstract
How did the Women’s Health Initiative change the labeling of menopausal hormone therapy? The speakers trace the clinical evidence and regulatory history and explain the reasoning for changes across four product categories.